Technical Meeting:

Reinforcing Access to HPV Vaccination & Cervical Cancer Screening and Treatment

Online Technical Meeting – April 2021

 

Meeting Objectives
  • Increasing access to HPV vaccination 

– Discuss experiences and opportunities to sustain/reinforce/implement HPV vaccination in different regions across the world, in general and during the Covid-19 pandemic.
– Discuss innovations that may help to achieve access targets such as, improved vaccination schedules, single dose, training and communication of Health Care Workers, etc.
– Review successful country examples with increased access to vaccination and high vaccination coverage.
– Discuss need for future research and trials.
– Discuss lessons learnt from Covid-19 and how these opportunities can be leveraged to increase access to vaccination. 

  • Increasing access to cervical cancer screening and treatment 

– Discuss experiences and opportunities to sustain/reinforce/implement screening and treatment programs across different regions in the world, in general and during the Covid-19 pandemic.
– Discuss innovations that may help to achieve access targets such as, self-sampling, availability of HPV tests, point of care screening technology, artificial intelligence-based screening, digitally reaching out to women, etc.
– Review successful country examples with increased access to screening and treatment.
– Discuss need for future research and trials.
– Discuss lessons learnt from Covid-19 and how to leverage these opportunities to increase access to cervical cancer screening and treatment.

​Background document​

DAY 1 – Thursday, 15 April 2021

SESSION 1: OPENING AND OBJECTIVES 

  • Welcome & Introduction 
    Alex Vorsters (University of Antwerp) 
    (Pdf, Video)

SESSION 2A: SUSTAINING/REINFORCING HPV VACCINATION
Chairs: Suzanne Garland & Liudmila Mosina 

  • Strategies used during Covid-19 and re-starting HPV vaccinationProgram in England
    Joanne Yarwood (Public Health England)
    (Pdf, Video)
  • Getting HPV vaccination back on track in the US & Update on National HPV Vaccination Roundtable’s efforts
    Noel Brewer (University of North Carolina)
    (Pdf, Video)
  • Regaining vaccine coverage in Colombia – lessons learnt
    Xavier Bosch (Institut Català d’Oncologia)  (Pdf, Video)
    Carlos Castro (Colombian League Against Cancer) (Pdf, Video)
  • Questions & Discussions (Video)

SESSION 2B: FUTURE APPROACHES FOR HPV VACCINATION
Chairs: Paul Bloem & Iacopo Baussano 

  • One dose – current status and findings
    Aimee Kreimer (NCI)
    (Pdf, Video)
  • HPV extended second dose – current status and findings
    Chantal Sauvageau (Quebec National Public Health Institute)
    (Pdf, Video)
  • Questions & discussions (Video)​
  • Are countries improving their HPV vaccination coverage? A trend analysis of WHO HPV vaccination coverage estimates 2010-2019
    Laia Bruni (Institut Català d’Oncologia)
    (Pdf, Video)
  • Questions & discussion (Video)

 

SESSION 3: LESSONS LEARNT FROM COVID-19: LEVERAGING OPPORTUNITIES FOR HPV VACCINATION 
Chair: Susanne Krüger Kjaer 

  • HPV vaccine acceptance in a time of Covid-19
    Heidi Larson (Vaccine Confidence Project LSHTM) 
    (Pdf, Video)
  • Lessons learned during deployment of a new smartphone-based safety monitoring system
    Tanya Myers (CDC) 
    (Pdf, Video)
  • Questions & Discussions (Video)​

SESSION 4: BREAKOUT SESSION 

      • Breakout Sessions (All participants)
        Chairs: Narendra Kumar Arora, Anna Giuliano & Silvia de Sanjosé

      • Topics:
        – Lessons Learnt and Way Forward
        – Sharing HPV vaccination programs experiences
      • Plenary feedback & Concluding points (Video)​

       

      DAY 2 – Friday, 16 April 2021

      INTRODUCTION

      • Welcome & Introduction
        Alex Vorsters (University of Antwerp) 
        (Pdf, Video)

      SESSION 5A: Re-STARTING/REINFORCING CERVICAL CANCER SCREENING AND TREATMENT PROGRAMS 
      Chairs: Jack Cuzick & Murat Gultekin

      • Impact of Covid-19 on cervical cancer screening programmes in LMICs
        Partha Basu (IARC)
        (Pdf, Video)
      • Short Update on cervical cancer screening programs and trials
        Yin Lin Woo (Malaysia) (Video) 
        Alejandra Castanon (England) (Video)
        Sharon Hanley (Japan) (Pdf, Video)
        Maribel Almonte (ESTAMPA study) (Pdf, Video)
      • Question & Discussions (Video)​

      SESSION 5B: OPPORTUNITIES FOR CO-TESTING (HIV & HPV)
      Chairs: Somesh Kumar & Alex Vorsters

      • Opportunities for co-testing (HIV & HPV): reinforcing access
        Julie Torode (UICC) (Pdf, Video)
        Lisa Huang (Expertise France) (Pdf, Video)
      • Question & Discussions (Video)​

      SESSION 6: LESSONS LEARNT FROM COVID-19: LEVERAGING OPPORTUNITIES FOR CERVICAL CANCER SCREENING AND TREATMENT
      Chairs: Marc Arbyn & Partha Basu 

      • Impact of Covid-19 testing on HPV testing
        Mario Poljak (University of Ljubljana) 
        (Pdf, Video)
      • Use of self-sampling for triage
        Jack Cuzick (Wolfson Institute of Preventive Medicine in London) 
        (Pdf, Video)

        Use of AI for cervical cancer testing and treatment

      • Use of AI for cervical cancer screening
        Silvia de Sanjosé (NCI, PATH) & 
        Kanan Desai (NCI)
        (Pdf, Video)
      • New Generation Colposcopies and the role of AI
        Murat Gultekin (Hacettepe University Hospitals) 
        (Pdf)
      • Questions & Discussion (Video)​

      SESSION 7: BREAKOUT SESSION

      • Breakout session
        Chairs: Mario Poljak & Eduardo Franco

      • – Discuss need for future research and trials.
        – Steps for reinforcing cervical cancer screening
        – Steps for reinforcing HPV vaccination
      • Plenary feedback (Video)​

      SESSION 8: CONCLUSION

      • Conclusions and Concluding remarks
        Marc Baay (P95) & Alex Vorsters (University of Antwerp)
        (Video)